Detailed view for PVX_118425

Basic information

TDR Targets ID: 268642
Plasmodium vivax, serine/threonine protein kinase, putative

Source Database / ID:  PlasmoDB 

pI: 9.4381 | Length (AA): 2443 | MW (Da): 273810 | Paralog Number: 0

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0

Druggability Group : DG5

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF00069   Protein kinase domain

Gene Ontology

Mouse over links to read term descriptions.
GO:0004713   protein tyrosine kinase activity  
GO:0004674   protein serine/threonine kinase activity  
GO:0004672   protein kinase activity  
GO:0005524   ATP binding  
GO:0006468   protein amino acid phosphorylation  

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

There are 10 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
53 481 2etr (A) 12 404 26.00 0 1 0.04 0.24
118 401 1yrp (A) 12 275 27.00 0 1 0.45 -0.68
7 481 4l9i (A) 50 523 21.00 0 1 0.250633 0.75
115 401 5dvt (A) 50 308 37.00 0 1 0.453479 -0.16
117 401 2y7j (A) 22 291 24.00 0 1 0.37986 -0.52
118 408 2hak (B) 52 314 39.00 0 1 0.229116 0.4
1252 1364 1w9r (A) 5 118 21.00 0.78 0.06 0.149455 -1.16
1886 2037 4ilo (A) 23 174 16.00 0.02 0.01 0.218419 -0.84
2130 2313 2ap3 (A) 6 194 16.00 0.58 0.01 0.215517 -0.58
2188 2342 4zt0 (A) 837 990 30.00 0.19 0.02 0.0584466 1.27

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
Upper 80-100% percentile intraerythrocytic - 40 hs, intraerythrocytic - 48 hs. Zhu L
Upregulation Percent Ranking Stage Dataset
Upper 60-80% percentile intraerythrocytic - 30 hs, intraerythrocytic - 36 hs. Zhu L
Upregulation Percent Ranking Stage Dataset
Mid 40-60% percentile intraerythrocytic - 6 hs, intraerythrocytic - 12 hs, intraerythrocytic - 24 hs. Zhu L
Upregulation Percent Ranking Stage Dataset
Lower 20-40% percentile intraerythrocytic - 18 hs. Zhu L
Show/Hide expression data references
  • Zhu L New insights into the Plasmodium vivax transcriptome using RNA-Seq.

Orthologs

Ortholog group members (OG5_137359)

Species Accession Gene Product
Babesia bovis BBOV_III003210   protein kinase domain containing protein
Candida albicans CaO19.2781   probable Ser Thr protein kinase, similar to RCK2
Candida albicans CaO19.10297   probable Ser Thr protein kinase, similar to RCK2
Plasmodium berghei PBANKA_1305200   serine/threonine protein kinase, putative
Plasmodium falciparum PF3D7_1441300   serine/threonine protein kinase, putative
Plasmodium knowlesi PKNH_1241000   serine/threonine protein kinase, putative
Plasmodium vivax PVX_118425   serine/threonine protein kinase, putative
Plasmodium yoelii PY05864   hypothetical protein
Plasmodium yoelii PY05330   Protein kinase domain, putative
Theileria parva TP04_0122   serine/threonine protein kinase, putative

Essentiality

PVX_118425 has one or more orthologs with essentiality data
Gene/Ortholog Organism Phenotype Source Study
PBANKA_1305200 Plasmodium berghei Dispensable plasmo
Show/Hide essentiality data references
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.


Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
Species Target Length Identity Alignment span Linked Drugs Reference
Rattus norvegicus Mitogen-activated protein kinase 1 358 aa 27.5% 316 aa Compounds References
Rattus norvegicus MAP kinase p38 alpha 360 aa 22.6% 314 aa Compounds References
Homo sapiens Cyclin-dependent kinase 1/cyclin B1 297 aa 26.2% 317 aa Compounds References
Patiria pectinifera Cdc2 300 aa 27.5% 316 aa Compounds References
Oryctolagus cuniculus cAMP-dependent protein kinase alpha-catalytic subunit 351 aa 25.5% 325 aa Compounds References
Oryctolagus cuniculus Cyclin-dependent kinase 4 189 aa 30.5% 167 aa Compounds References
Rattus norvegicus Cell division protein kinase 5 292 aa 25.6% 316 aa Compounds References
Bos taurus cAMP-dependent protein kinase alpha-catalytic subunit 351 aa 26.2% 325 aa Compounds References
Rattus norvegicus cAMP-dependent protein kinase alpha-catalytic subunit 351 aa 26.2% 325 aa Compounds References
Rattus norvegicus Mitogen-activated protein kinase 8 411 aa 25.7% 331 aa Compounds References
Plasmodium falciparum (isolate 3D7) Cell division control protein 2 homolog 288 aa 26.0% 319 aa Compounds References

Obtained from network model

Ranking Plot


Putative Drugs List


Compound Raw Global Species
0.0011 1 0.5
0.0067 0.5 0.5
0.0012 0.5 0.5
0.0091 1 0.5
0.0037 1 0.5
0.0059 1 1
0.0081 1 0.5
0.0066 0.3101 0.5
0.0098 0.3242 0.2614
0.0016 0.5 0.5
0.0081 0.5 0.5
0.0007 0.5 0.5
0.0036 0.5 0.5
0.0012 0.5 0.5
0.0016 0.5 0.5
0.0059 1 1
0.0039 0.5 0.5
0.0033 0.5 0.5
0.0029 0.5 0.5
0.0032 0.5 0.5
0.0059 1 1
0.0032 0.5 0.5
0.0003 0.5 0.5
0.0063 0.7244 0.7244
0.0026 0.5 0.5
0.0033 1 1
0.0004 0.5 0.5
0.0062 0.6935 0.5
0.0008 0.5 0.5
0.0064 0.3377 0.5
0.0069 0.3067 1
0.0027 1 0.5
0.0022 0.5 0.5
0.0018 0.5 0.5
0.0061 0.6883 1
0.0039 0.5 0.5
0.0093 0.8828 0
0.0063 1 1
0.0042 0.5 0.5
0.0007 0.5 0.5
0.0007 0.5 0.5
0.0092 1 0.5
0.0039 0.9485 0.5
0.0012 0.5 0.5
0.0088 0.4477 0.5
0.0056 1 0.5
0.0023 0.5 0.5

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier PVX_118425 (Plasmodium vivax), serine/threonine protein kinase, putative
Title for this comment
Comment